{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:57:02Z","timestamp":1771027022924,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.151","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T23:14:14Z","timestamp":1377904454000},"page":"151-155","source":"Crossref","is-referenced-by-count":11,"title":["Portal Vein Thrombosis during Eltrombopag Treatment for Immune Thrombocytopenic Purpura in a Patient with Liver Cirrhosis due to Hepatitis C Viral Infection"],"prefix":"10.3960","volume":"53","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Muranaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Garcia-Tsao G, Lim JK ; Members of Veterans Affairs Hepatitis C Resource Center Program : Management and treatment of patients with cirrhosis and portal hypertension : recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104:1802-1829, 2009","DOI":"10.1038\/ajg.2009.191"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, <I>et al<\/I>.: Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 357:2227-2236, 2007","DOI":"10.1056\/NEJMoa073255"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, <I>et al<\/I>.: Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med 169:357-363, 2009","DOI":"10.1001\/archinternmed.2008.576"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, <I>et al<\/I>.: International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168-186, 2010","DOI":"10.1182\/blood-2009-06-225565"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Cines DB, Bussel JB, Liebman HA, Luning Prak ET : The ITP syndrome : pathogenic and clinical diversity. Blood 113:6511-6521, 2009","DOI":"10.1182\/blood-2009-01-129155"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Stasi R: Immune thrombocytopenic purpura : the treatment paradigm. Eur J Haematol Suppl. (Suppl 71):13-19, 2009","DOI":"10.1111\/j.1600-0609.2008.01208.x"},{"key":"7","unstructured":"7 Cheng G, Saleh MN, Marcher C, Vasey S, Mayer B, <I>et al<\/I>.: Eltrombopag for management of chronic immune thrombocytopenia (RAISE) : a 6-month, randomised, phase 3 study. Lancet 377:393-402, 2011"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kuter DJ: Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 60:193-206, 2009","DOI":"10.1146\/annurev.med.60.042307.181154"},{"key":"9","unstructured":"9 Komori A, Seike M, Fujiyama S, Watanabe H, Mukouzaka A, <I>et al<\/I>.: Phase II trial of eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. The Japanese Society of Hepatology. Kanzo 52 (suppl 1) : 147A, 2011 (<I>in Japanese<\/I>)"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dultz G, Kronenberger B, Azizi A, Mihm U, Vogl TJ, <I>et al<\/I>.: Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. J Hepatol 55:229-232, 2011","DOI":"10.1016\/j.jhep.2011.01.020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, <I>et al<\/I>.: The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190-4207, 2011","DOI":"10.1182\/blood-2010-08-302984"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ponziani FR, Zocco MA, Tortora A, Gasbarrini A : Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients ? Expert Opin Pharmacother 11:1479-1487, 2010","DOI":"10.1517\/14656561003749264"},{"key":"13","unstructured":"13 Garc&#237;a-Fuster MJ, Abdilla N, Fabi&aacute; MJ, Fern&aacute;ndez C, Oliver V, <I>et al<\/I>.: Venous thromboembolism and liver cirrhosis. Rev Esp Enferm Dig 100:259-262, 2008 (<I>in Spanish<\/I>)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 DeLeve LD, Valla DC, Garcia-Tsao G: American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 49:1729-1764, 2009","DOI":"10.1002\/hep.22772"},{"key":"15","unstructured":"15 Rajani R, Bj&ouml;rnsson E, Bergquist A, Danielsson A, Gustavsson A, <I>et al<\/I>.: The epidemiology and clinical features of portal vein thrombosis : a multicentre study. Aliment Pharmacol Ther 32:1154-1162, 2010"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:28Z","timestamp":1621539988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/2\/53_151\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.151","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}